Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile.

Garcia-Broncano P, Maddali S, Einkauf KB, Jiang C, Gao C, Chevalier J, Chowdhury FZ, Maswabi K, Ajibola G, Moyo S, Mohammed T, Ncube T, Makhema J, Jean-Philippe P, Yu XG, Powis KM, Lockman S, Kuritzkes DR, Shapiro R, Lichterfeld M.

Sci Transl Med. 2019 Nov 27;11(520). pii: eaax7350. doi: 10.1126/scitranslmed.aax7350.

PMID:
31776292
2.

Author Correction: CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome.

Kulkarni S, Lied A, Kulkarni V, Rucevic M, Martin MP, Walker-Sperling V, Anderson SK, Ewy R, Singh S, Nguyen H, McLaren PJ, Viard M, Naranbhai V, Zou C, Lin Z, Gatanaga H, Oka S, Takiguchi M, Thio CL, Margolick J, Kirk GD, Goedert JJ, Hoots WK, Deeks SG, Haas DW, Michael N, Walker B, Le Gall S, Chowdhury FZ, Yu XG, Carrington M.

Nat Immunol. 2019 Nov;20(11):1555. doi: 10.1038/s41590-019-0516-9.

PMID:
31548709
3.

CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome.

Kulkarni S, Lied A, Kulkarni V, Rucevic M, Martin MP, Walker-Sperling V, Anderson SK, Ewy R, Singh S, Nguyen H, McLaren PJ, Viard M, Naranbhai V, Zou C, Lin Z, Gatanaga H, Oka S, Takiguchi M, Thio CL, Margolick J, Kirk GD, Goedert JJ, Hoots WK, Deeks SG, Haas DW, Michael N, Walker B, Le Gall S, Chowdhury FZ, Yu XG, Carrington M.

Nat Immunol. 2019 Jul;20(7):824-834. doi: 10.1038/s41590-019-0406-1. Epub 2019 Jun 17. Erratum in: Nat Immunol. 2019 Nov;20(11):1555.

PMID:
31209403
4.

Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy.

Einkauf KB, Lee GQ, Gao C, Sharaf R, Sun X, Hua S, Chen SM, Jiang C, Lian X, Chowdhury FZ, Rosenberg ES, Chun TW, Li JZ, Yu XG, Lichterfeld M.

J Clin Invest. 2019 Mar 1;129(3):988-998. doi: 10.1172/JCI124291. Epub 2019 Jan 28.

5.

Metabolic pathway activation distinguishes transcriptional signatures of CD8+ T cells from HIV-1 elite controllers.

Chowdhury FZ, Ouyang Z, Buzon M, Walker BD, Lichterfeld M, Yu XG.

AIDS. 2018 Nov 28;32(18):2669-2677. doi: 10.1097/QAD.0000000000002007.

6.

Preferential susceptibility of Th9 and Th2 CD4+ T cells to X4-tropic HIV-1 infection.

Orlova-Fink N, Chowdhury FZ, Sun X, Harrington S, Rosenberg ES, Yu XG, Lichterfeld M.

AIDS. 2017 Oct 23;31(16):2211-2215. doi: 10.1097/QAD.0000000000001630.

7.

Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells.

Lee GQ, Orlova-Fink N, Einkauf K, Chowdhury FZ, Sun X, Harrington S, Kuo HH, Hua S, Chen HR, Ouyang Z, Reddy K, Dong K, Ndung'u T, Walker BD, Rosenberg ES, Yu XG, Lichterfeld M.

J Clin Invest. 2017 Jun 30;127(7):2689-2696. doi: 10.1172/JCI93289. Epub 2017 Jun 19.

8.

HLA-G+ HIV-1-specific CD8+ T cells are associated with HIV-1 immune control.

Viganò S, Negrón JJ, Tse S, Chowdhury FZ, Lichterfeld M, Yu XG.

AIDS. 2017 Jan 14;31(2):207-212. doi: 10.1097/QAD.0000000000001326.

9.

Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions.

Chowdhury FZ, Estrada LD, Murray S, Forman J, Farrar JD.

PLoS One. 2014 Mar 18;9(3):e92187. doi: 10.1371/journal.pone.0092187. eCollection 2014.

10.

STAT2: A shape-shifting anti-viral super STAT.

Chowdhury FZ, Farrar JD.

JAKSTAT. 2013 Jan 1;2(1):e23633. doi: 10.4161/jkst.23633. Review.

11.

SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature.

Becker AM, Dao KH, Han BK, Kornu R, Lakhanpal S, Mobley AB, Li QZ, Lian Y, Wu T, Reimold AM, Olsen NJ, Karp DR, Chowdhury FZ, Farrar JD, Satterthwaite AB, Mohan C, Lipsky PE, Wakeland EK, Davis LS.

PLoS One. 2013 Jun 24;8(6):e67003. doi: 10.1371/journal.pone.0067003. Print 2013.

12.

IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo.

Chowdhury FZ, Ramos HJ, Davis LS, Forman J, Farrar JD.

Blood. 2011 Oct 6;118(14):3890-900. doi: 10.1182/blood-2011-05-357111. Epub 2011 Aug 10.

13.

Anaerobic respiration of Escherichia coli in the mouse intestine.

Jones SA, Gibson T, Maltby RC, Chowdhury FZ, Stewart V, Cohen PS, Conway T.

Infect Immun. 2011 Oct;79(10):4218-26. doi: 10.1128/IAI.05395-11. Epub 2011 Aug 8.

14.

Glycogen and maltose utilization by Escherichia coli O157:H7 in the mouse intestine.

Jones SA, Jorgensen M, Chowdhury FZ, Rodgers R, Hartline J, Leatham MP, Struve C, Krogfelt KA, Cohen PS, Conway T.

Infect Immun. 2008 Jun;76(6):2531-40. doi: 10.1128/IAI.00096-08. Epub 2008 Mar 17.

15.

Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine.

Fabich AJ, Jones SA, Chowdhury FZ, Cernosek A, Anderson A, Smalley D, McHargue JW, Hightower GA, Smith JT, Autieri SM, Leatham MP, Lins JJ, Allen RL, Laux DC, Cohen PS, Conway T.

Infect Immun. 2008 Mar;76(3):1143-52. doi: 10.1128/IAI.01386-07. Epub 2008 Jan 7.

16.

Respiration of Escherichia coli in the mouse intestine.

Jones SA, Chowdhury FZ, Fabich AJ, Anderson A, Schreiner DM, House AL, Autieri SM, Leatham MP, Lins JJ, Jorgensen M, Cohen PS, Conway T.

Infect Immun. 2007 Oct;75(10):4891-9. Epub 2007 Aug 13.

Supplemental Content

Loading ...
Support Center